Fed Chair Powell Faces Crucial Decision After Criminal Probe Concludes Clarivate CLVT Q1 2026 Earnings Surprise EPS 018 Up Significant Kelly Services KELYA Q1 2026 Earnings Miss by Significant Key Takeaways Alcon ALC Up 310 Is There More Room to Run 20260518 Dana DAN Q1 2026 Earnings Slump EPS Falls Short of 036 Target Swatch CEO Says Overcrowding Like Hell Is Good Sign After Pocket Watch Launch Sparks UK Store Chaos Grab GRAB Q1 2026 Earnings 003 EPS Surges Past 002 Estimates Valley VLYPO Q1 2026 Earnings Shine Revenue Growth Fuels Beat Evercore ISI Unveils Formula for Gauging When Prediction Markets Are Most Effective Micron Reaches 1 Trillion Market Cap as AI Memory Demand Surges As Live Music Prices Surge Concertgoers Turn Selective This Summer Abbott Laboratories Shares Decline Amid Nutrition Business Challenges Agricultural Gold Loans Surge 40 as Farmers Capitalize on Rising Gold Prices Kotak Mahindra Bank UK Dirty Money Flows Estimated at 325bn Annually Sparking Regulatory Concerns BiomX Inc PHGE Q4 2025 Earnings Deep EPS Miss Overshadowed by 98 Stock Surge CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6 AMR Q1 2026 Earnings Metallurgical Coal Producer Posts Unexpected Loss as Earnings Miss Estimates by Wide Margin ACGLO Q1 2026 Earnings EPS Misses Estimates Amid Mixed Underwriting Conditions TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher ProCap BRR Stock Analysis 854 Loss Key Levels 20260519 Arvind Sanger Cautiously Optimistic on Indian Markets Eyes Earnings Revival Booking BKNG Gains 057 Support Holds at 14816 20260519 Global Markets Rally on TrumpXi Summit Breakthrough Strait of Hormuz Pledge Boosts Sentiment Better Home BETRW Holds 020 Direction Awaited 20260514 Versant Media Group Shares Climb on Strong Q1 Results as Company Embraces Independence Pfizers Pneumococcal Vaccine Candidate Shows Strong Phase 2 Results Billionaires Maintain Interest Gogoro Inc Q1 2026 Earnings Wider Net Loss Reported Amidst Operational Adjustments GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology ETSY Q1 2026 Earnings Earnings Beat Expectations with Strong EPS Surprise REX Q3 2001 Earnings EPS Beats Estimates by 23 on Strong Operating Performance AACG Q3 2024 Earnings Narrowed Loss Signals Resilience Amid Strategic Pivot PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus FCRX Q1 2026 Earnings Slight EPS Miss Reflects Stable but Unspectacular Quarter TPST Q1 2026 Earnings Deep EPS Miss Highlights ClinicalStage Biotech Challenges